MARK GREGORY GARZOTTO, MD
Urology at Sam Jackson Park Rd, Portland, OR

License number
Oregon MD22159
Category
Radiology
Type
Urology
Address
Address
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Phone
(503) 494-7760

Personal information

See more information about MARK GREGORY GARZOTTO at radaris.com
Name
Address
Phone
Mark G Garzotto, age 61
4235 Hoyt St, Portland, OR 97213
Mark W Garzotto
2700 148Th Ave, Portland, OR 97236
(503) 232-3554
Mark Garzotto
1520 SE 54Th Ave, Portland, OR 97215
(503) 232-3554

Professional information

Mark G Garzotto Photo 1

Dr. Mark G Garzotto, Portland OR - MD (Doctor of Medicine)

Specialties:
Urology
Address:
Oregon Health/Sciences Univ-URO
3303 SW Bond Ave, Portland 97239
(503) 346-1500 (Phone)
VA Medical Center Urology
3710 SW Us Veterans Hospital Rd, Portland 97239
(503) 220-8262 (Phone)
Certifications:
Urology, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Louisiana State Univ School Of Medicine In New Orleans
Graduated: 1990
University Of Fl College Of Med


Mark Gregory Garzotto Photo 2

Mark Gregory Garzotto, Portland OR

Specialties:
Urology, Surgery
Work:
Oregon Health & Science University
3181 SW Sam Jackson Park Rd, Portland, OR 97239 Urology Adult
3303 SW Bond Ave, Portland, OR 97239 Veterans Affairs Medical Center - Portland
3710 SW Us Vetrn Hosp Rd, Portland, OR 97239
Education:
Louisiana State University at New Orleans (1990)


Mark Gregory Garzotto Photo 3

Mark Gregory Garzotto, Portland OR

Specialties:
Urologist
Address:
3181 Sw Sam Jackson Park Rd, Portland, OR 97239
Board certifications:
American Board of Urology Certification in Urology


Mark Garzotto Photo 4

Estrogen Administration For Treating Male Cognitive Dysfunction Or Improving Male Cognitive Function

US Patent:
2006001, Jan 26, 2006
Filed:
Dec 30, 2004
Appl. No.:
11/027006
Inventors:
Tomasz Beer - Portland OR, US
Lisa Bland - Portland OR, US
Mark Garzotto - Portland OR, US
Jeri Janowsky - Portland OR, US
International Classification:
A61K 31/56
US Classification:
514182000
Abstract:
Disclosed are methods of treating a male subject diagnosed with cognitive dysfunction that include administering an estrogenic agent, or a pharmaceutically acceptable salt or complex thereof, to the male subject. Also disclosed is a method of improving cognitive function in a hypogonadal male subject that includes transdermally administering to the male subject a therapeutically effective amount of an estrogenic agent, or a pharmaceutically acceptable salt or complex thereof. Further disclosed is a method of improving cognitive function in a male subject that includes administering to the male subject an estrogenic agent, or a pharmaceutically acceptable salt or complex thereof, at a dosage of about 0.025 to about 1.5 mg/day.